Capitol Hill Scrutiny Grows Over Iran War Strategy and Cost

Lawmakers on Capitol Hill are raising new questions about the war involving the Iran, following testimony from U.S. Director of National Intelligence Tulsi Gabbard before Congress.

Testifying before the United States Senate Intelligence Committee, Gabbard stated in her written testimony that there was no evidence Iran was seeking to restore its capacity to enrich uranium for a nuclear weapons program. However, she did not include that point in her verbal testimony to the committee.

Democratic senators questioned the omission, noting it appeared to differ from earlier statements by Donald Trump, who had argued at the start of the war that the conflict was justified due to the imminent threat of Iran acquiring nuclear weapons.

Gabbard also testified before the United States House Permanent Select Committee on Intelligence, where she discussed differing objectives between the United States and Israel in the conflict. According to her testimony, the U.S. strategy is focused primarily on destroying Iran’s ballistic missile capabilities, while Israel appears more focused on regime change and targeting senior Iranian leadership.

Meanwhile, the Office of Management and Budget is expected to introduce a supplemental funding request for the Iran war that could reach as high as $230 billion, far exceeding earlier public estimates that ranged from $50 billion to $100 billion.

The proposal would focus heavily on replenishing U.S. weapons and munitions used during the conflict. Because of its size, the funding request is expected to trigger a major debate in Congress, and it remains uncertain whether lawmakers will approve it.